ImmunityBio Inc

NASDAQ:IBRX 4:00:00 PM EDT

1.66

-0.05 (-2.92%)

: $1.66 0.00 (0.00%)

Market Cap (Intraday)	723.52M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.03 Million
Adjusted EPS	-$0.22

See more estimates

10-Day MA	$1.63
50-Day MA	$2.87
200-Day MA	$4.36

See more pivots

ImmunityBio Inc Stock, NASDAQ:IBRX

3350 John Hopkins Court, San Diego, California 92121

United States of America

Phone: +1.858.633.0300

Number of Employees: 725

http://www.immunitybio.com

Description

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.